Advertisement

Dermatology

  • Anna Cristina Garza-Mayers
  • Daniela KroshinskyEmail author
Chapter
Part of the Current Clinical Psychiatry book series (CCPSY)

Abstract

Dermatologic disease and skin-related concerns are as prevalent in individuals with autism spectrum disorder (ASD) as in the general population. There is data to suggest barriers to diagnosis and difficulty with medication adherence may increase morbidity and disease burden in this population. Basic skin care and a general dermatologic examination should take into consideration a patient’s sensory (particularly tactile) processing as well as communication and decision-making abilities. Treatment of common skin disorders should be tailored to the individual patient’s goals and tolerance. Underlying disease should be ruled out in cases of self-injurious behavior, and any presenting skin complaints should take into account medication and diet. Skin findings may be indicative of systemic disease and should be approached with a wide differential in both pediatric and adult patients with ASD.

Keywords

Skin care Itch Skin picking Drug rash Topical medication Acne Nutritional deficiency 

References

  1. 1.
    Accordino RE, Lucarelli J, Yan AC. Cutaneous disease in autism spectrum disorder: a review. Pediatr Dermatol. 2015;32(4):455–60. PubMed PMID: 25824343.CrossRefGoogle Scholar
  2. 2.
    Cermak SA, Curtin C, Bandini LG. Food selectivity and sensory sensitivity in children with autism spectrum disorders. J Am Diet Assoc. 2010;110(2):238–46. PubMed PMID: 20102851. Pubmed Central PMCID: 3601920.CrossRefGoogle Scholar
  3. 3.
    Cole JA, Warthan MM, Hirano SA, Gowen CW Jr, Williams JV. Scurvy in a 10-year-old boy. Pediatr Dermatol. 2011;28(4):444–6. PubMed PMID: 20561240.CrossRefGoogle Scholar
  4. 4.
    Das S, Reynolds RV. Recent advances in acne pathogenesis: implications for therapy. Am J Clin Dermatol. 2014;15(6):479–88. PubMed PMID: 25388823.CrossRefGoogle Scholar
  5. 5.
    Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for cutaneous adverse drug reactions. American Academy of Dermatology. J Am Acad Dermatol. 1996;35(3 Pt 1):458–61. PubMed PMID: 8784285.PubMedGoogle Scholar
  6. 6.
    DSM-5. Autism spectrum disorder. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.Google Scholar
  7. 7.
    Duerden EG, Oatley HK, Mak-Fan KM, McGrath PA, Taylor MJ, Szatmari P, et al. Risk factors associated with self-injurious behaviors in children and adolescents with autism spectrum disorders. J Autism Dev Disord. 2012;42(11):2460–70. PubMed PMID: 22422338.CrossRefGoogle Scholar
  8. 8.
    Ellis EM, Ala’i-Rosales SS, Glenn SS, Rosales-Ruiz J, Greenspoon J. The effects of graduated exposure, modeling, and contingent social attention on tolerance to skin care products with two children with autism. Res Dev Disabil. 2006;27(6):585–98. PubMed PMID: 16242911.CrossRefGoogle Scholar
  9. 9.
    Elmariah SB. Careful considerations concerning psychogenic itch. JAMA Intern Med. 2015;175(11):1861. PubMed PMID: 26524738.CrossRefGoogle Scholar
  10. 10.
    Elmariah SB, Lerner EA. Topical therapies for pruritus. Semin Cutan Med Surg. 2011;30(2):118–26. PubMed PMID: 21767774. Pubmed Central PMCID: 3139917.CrossRefGoogle Scholar
  11. 11.
    Erickson CA, Posey DJ, Stigler KA, Mullett J, Katschke AR, McDougle CJ. A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology. 2007;191(1):141–7. PubMed PMID: 17016714.CrossRefGoogle Scholar
  12. 12.
    Ferguson J. Photosensitivity due to drugs. Photodermatol Photoimmunol Photomed. 2002;18(5):262–9. PubMed PMID: 12390668.CrossRefGoogle Scholar
  13. 13.
    Hardan AY, Jou RJ, Handen BL. A retrospective assessment of topiramate in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2004;14(3):426–32. PubMed PMID: 15650499.CrossRefGoogle Scholar
  14. 14.
    Hertzman M. Galantamine in the treatment of adult autism: a report of three clinical cases. Int J Psychiatry Med. 2003;33(4):395–8. PubMed PMID: 15152789.CrossRefGoogle Scholar
  15. 15.
    Hunt A, Shepherd C. A prevalence study of autism in tuberous sclerosis. J Autism Dev Disord. 1993;23(2):323–39. PubMed PMID: 8331050.CrossRefGoogle Scholar
  16. 16.
    Hyman SL, Stewart PA, Schmidt B, Cain U, Lemcke N, Foley JT, et al. Nutrient intake from food in children with autism. Pediatrics. 2012;130(Suppl 2):S145–53. PubMed PMID: 23118245. Pubmed Central PMCID: 4536585.CrossRefGoogle Scholar
  17. 17.
    Jen M, Yan AC. Syndromes associated with nutritional deficiency and excess. Clin Dermatol. 2010;28(6):669–85. PubMed PMID: 21034991.CrossRefGoogle Scholar
  18. 18.
    Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol. 2000;136(10):1231–6. PubMed PMID: 11030769.CrossRefGoogle Scholar
  19. 19.
    Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071–80. PubMed PMID: 23855313.CrossRefGoogle Scholar
  20. 20.
    Kroshinsky D. Adolescent dermatology. In: Goldstein MA, editor. The MassGeneral Hospital for children adolescent medicine handbook. New York: Springer; 2011. p. 43–9.CrossRefGoogle Scholar
  21. 21.
    Kuhaneck HM, Chisholm EC. Improving dental visits for individuals with autism spectrum disorders through an understanding of sensory processing. Spec Care Dentist. 2012;32(6):229–33. PubMed PMID: 23095065.CrossRefGoogle Scholar
  22. 22.
    Lang R, Didden R, Machalicek W, Rispoli M, Sigafoos J, Lancioni G, et al. Behavioral treatment of chronic skin-picking in individuals with developmental disabilities: a systematic review. Res Dev Disabil. 2010;31(2):304–15. PubMed PMID: 19963341.CrossRefGoogle Scholar
  23. 23.
    Leekam SR, Nieto C, Libby SJ, Wing L, Gould J. Describing the sensory abnormalities of children and adults with autism. J Autism Dev Disord. 2007;37(5):894–910. PubMed PMID: 17016677.CrossRefGoogle Scholar
  24. 24.
    Logan SL, Nicholas JS, Carpenter LA, King LB, Garrett-Mayer E, Charles JM. High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network. Ann Epidemiol. 2012;22(1):1–8. PubMed PMID: 22153288. Pubmed Central PMCID: 3240812.CrossRefGoogle Scholar
  25. 25.
    Millward C, Ferriter M, Calver S, Connell-Jones G. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev. 2008;(2):CD003498. PubMed PMID: 18425890. Pubmed Central PMCID: 4164915.Google Scholar
  26. 26.
    Monks G, Juracek L, Weigand D, Magro C, Cornelison R, Crowson AN. A case of scurvy in an autistic boy. J Drugs Dermatol JDD. 2002;1(1):67–9. PubMed PMID: 12847759.PubMedGoogle Scholar
  27. 27.
    Moore JW, Fisher WW, Pennington A. Systematic application and removal of protective equipment in the assessment of multiple topographies of self-injury. J Appl Behav Anal. 2004;37(1):73–7. PubMed PMID: 15154217. Pubmed Central PMCID: 1284479.CrossRefGoogle Scholar
  28. 28.
    Ohtoshi S, Kitami Y, Sueki H, Nakada T. Utility of patch testing for patients with drug eruption. Clin Exp Dermatol. 2014;39(3):279–83. PubMed PMID: 24635061.CrossRefGoogle Scholar
  29. 29.
    Oza VS, Marco E, Frieden IJ. Improving the dermatologic care of individuals with autism: a review of relevant issues and a perspective. Pediatr Dermatol. 2015;32(4):447–54. PubMed PMID: 25779667.CrossRefGoogle Scholar
  30. 30.
    Paley K, Prevost N, English JC 3rd. Unna sleeve for neurotic excoriations. Cutis. 2010;85(3):149–52. PubMed PMID: 20408514.PubMedGoogle Scholar
  31. 31.
    Romanelli M, Rhodes A. Guanfacine-induced lichenoid drug eruption in a child with autism and attention deficit hyperactivity disorder. Pediatr Dermatol. 2014;31(5):614–5. PubMed PMID: 23869619.CrossRefGoogle Scholar
  32. 32.
    Schieve LA, Gonzalez V, Boulet SL, Visser SN, Rice CE, Van Naarden Braun K, et al. Concurrent medical conditions and health care use and needs among children with learning and behavioral developmental disabilities, National Health Interview Survey, 2006–2010. Res Dev Disabil. 2012;33(2):467–76. PubMed PMID: 22119694.CrossRefGoogle Scholar
  33. 33.
    Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol. 2008;58(1):33–40. PubMed PMID: 17919775.CrossRefGoogle Scholar
  34. 34.
    Sorrell J, Salvaggio H, Garg A, Guo L, Duck SC, Paller AS. Eruptive xanthomas masquerading as molluscum contagiosum. Pediatrics. 2014;134(1):e257–60. PubMed PMID: 24918225.CrossRefGoogle Scholar
  35. 35.
    Stern RS. Clinical practice. Exanthematous drug eruptions. N Engl J Med. 2012;366(26):2492–501. PubMed PMID: 22738099.CrossRefGoogle Scholar
  36. 36.
    Swanson L, Colven RM. Approach to the patient with a suspected cutaneous adverse drug reaction. Med Clin North Am. 2015;99(6):1337–48. PubMed PMID: 26476256.CrossRefGoogle Scholar
  37. 37.
    Thiboutot D, Gollnick H, Bettoli V, Dreno B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the global alliance to improve outcomes in acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1–50. PubMed PMID: 19376456.CrossRefGoogle Scholar
  38. 38.
    Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. N Engl J Med. 2013;368(17):1625–34. PubMed PMID: 23614588.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Anna Cristina Garza-Mayers
    • 1
  • Daniela Kroshinsky
    • 2
    Email author
  1. 1.Harvard Combined Program in Dermatology, Massachusetts General HospitalBostonUSA
  2. 2.Department of Dermatology, Massachusetts General HospitalBostonUSA

Personalised recommendations